# Nierinsufficiëntie bij hartfalen verhoogt sterfte en heropnames aanzienlijk — Ecuadorian registry

*geplaatst 2026-11-18 · Nierziekte · Archivos de cardiologia de Mexico · doi 10.24875/ACM.25000259 · https://hartvaat.nl/2026/11/10/nierinsufficientie-bij-hartfalen-verhoogt-sterfte-en-heropnames-aanzienlijk-ecua/*

In een retrospectief cohort van 706 hartfalenpatiënten in Ecuador bleek 57,8% nierinsufficiëntie (eGFR < 60 mL/min/1.73m²) te hebben, met de hoogste prevalentie bij HFrEF (57,8%) en HFpEF (53,5%). Patiënten met nierinsufficiëntie hadden een significant hogere kans op all-cause sterfte (49,3% vs. 26,8%), cardiovasculaire sterfte en hartfalenhospitalisaties. Deze bevindingen onderstrepen dat nierfunctie een cruciale prognostische marker is bij hartfalen, wat aandacht vraagt voor geïntegreerde cardiorenale zorg en vroegtijdige risicoadaptatie.

## English: Chronic kidney disease in heart failure: results from an Ecuadorian registry.

In a retrospective single-center registry of 706 heart failure patients in Ecuador, 57.8% had chronic kidney disease (eGFR < 60 mL/min/1.73m²), with the highest prevalence in HFrEF (57.8%) and HFpEF (53.5%). Patients with CKD faced significantly higher rates of all-cause mortality (49.3% vs. 26.8%), cardiovascular mortality, and heart failure hospitalizations. These findings reinforce CKD as a key prognostic marker in heart failure, highlighting the need for integrated cardiorenal management and closer monitoring in clinical practice.

## Abstract (original, from the publication)

OBJECTIVES: Heart failure (HF) frequently coexists with chronic kidney disease (CKD), a combination that is associated with worse outcomes. Data from Ecuador remain limited. We estimated the prevalence of CKD among patients with HF and described prognostic impact according to left ventricular ejection fraction (LVEF). METHODS: A retrospective study was conducted using a single-center HF registry in Ecuador. CKD was defined as an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73m2. HF was categorized by LVEF into reduced (HF with reduced ejection fraction [HFrEF], ≤ 40%), mildly reduced (HF with mildly reduced ejection fraction [HFmrEF], 41-49%), and preserved (HF with preserved ejection fraction [HFpEF], ≥ 50%). The median follow-up was 2.28 years. RESULTS: Among 706 patients (age 69.9 ± 13.3 years; 31.4% women), 50.3% had an eGFR ≥ 60, 33.1% had an eGFR of 30-59, and 16.6% had an eGFR < 30 mL/min/1.73m2. CKD prevalence was 57.8% in HFrEF, 41.8% in HFmrEF, and 53.5% in HFpEF (p = 0.003). CKD patients were older and had higher rates of hypertension (HT), atrial fibrillation, and cerebrovascular disease, with higher NT-proBNP levels, larger diastolic diameters, lower LVEF, more tricuspid regurgitation, and pulmonary HT (all p < 0.05). CKD was associated with increased all-cause mortality (49.3 vs. 26.8%), cardiovascular mortality (28.8 vs. 11.8%), all-cause hospitalizations (47.6 vs. 25.9%), and HF hospitalizations (22.2 vs. 11.0%). Predictors of mortality were LVEF ≤ 40% (Hazard ratio [HR] 1.5, 95% confidence interval [CI] 1.1-2.2; p = 0.048), moderate/severe tricuspid regurgitation (HR 1.6, 95% CI 1.1-2.2; p = 0.008), and prior HF hospitalization (HR 2.2, 95% CI 1.6-3.1; p < 0.001). CONCLUSIONS: CKD was highly prevalent among patients with HF, particularly among those with LVEF < 50%. Its presence was associated with a more adverse clinical and echocardiographic profile, as well as higher hospitalization, all-cause mortality, and cardiovascular mortality.

Auteurs: Ronald E Pucha-Pesántez, Luis Moreno-Rondón, María E Ortega-Armas, Robert Alarcón-Cedeño, Diego Pulla, Mario D Gómez, Diego Villavicencio, Alex F Castro-Mejía

---
Bron: Archivos de cardiologia de Mexico, https://doi.org/10.24875/ACM.25000259. Bijgewerkt 2026-11-11T02:24:21Z. Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.
